BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28810742)

  • 1. Determination of Rate-Limiting Factor for Formation of Beta-Catenin Destruction Complexes Using Absolute Protein Quantification.
    Kitazawa M; Hatta T; Ogawa K; Fukuda E; Goshima N; Natsume T
    J Proteome Res; 2017 Oct; 16(10):3576-3584. PubMed ID: 28810742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Transcription Factor SP1 by the β-Catenin Destruction Complex Modulates Wnt Response.
    Mir R; Sharma A; Pradhan SJ; Galande S
    Mol Cell Biol; 2018 Nov; 38(22):. PubMed ID: 30181396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thr160 of Axin1 is critical for the formation and function of the β-catenin destruction complex.
    Koyama-Nasu R; Hayashi T; Nasu-Nishimura Y; Akiyama T; Yamanaka R
    Biochem Biophys Res Commun; 2015 Apr; 459(3):411-5. PubMed ID: 25735981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supramolecular assembly of the beta-catenin destruction complex and the effect of Wnt signaling on its localization, molecular size, and activity in vivo.
    Schaefer KN; Bonello TT; Zhang S; Williams CE; Roberts DM; McKay DJ; Peifer M
    PLoS Genet; 2018 Apr; 14(4):e1007339. PubMed ID: 29641560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APC mutations disrupt β-catenin destruction complex condensates organized by Axin phase separation.
    Zhang D; Ni QQ; Wang SY; He WF; Hong ZX; Liu HY; Chen XH; Chen LJ; Han FY; Zhang LJ; Li XM; Ding YQ; Jiao HL; Ye YP
    Cell Mol Life Sci; 2024 Jan; 81(1):57. PubMed ID: 38279052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase separation of Axin organizes the β-catenin destruction complex.
    Nong J; Kang K; Shi Q; Zhu X; Tao Q; Chen YG
    J Cell Biol; 2021 Apr; 220(4):. PubMed ID: 33651074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of ICAT as an APC Inhibitor, Revealing Wnt-Dependent Inhibition of APC-Axin Interaction.
    Ji L; Lu B; Wang Z; Yang Z; Reece-Hoyes J; Russ C; Xu W; Cong F
    Mol Cell; 2018 Oct; 72(1):37-47.e4. PubMed ID: 30197296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reconstitution of the destruction complex defines roles of AXIN polymers and APC in β-catenin capture, phosphorylation, and ubiquitylation.
    Ranes M; Zaleska M; Sakalas S; Knight R; Guettler S
    Mol Cell; 2021 Aug; 81(16):3246-3261.e11. PubMed ID: 34352208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APC controls Wnt-induced β-catenin destruction complex recruitment in human colonocytes.
    Parker TW; Neufeld KL
    Sci Rep; 2020 Feb; 10(1):2957. PubMed ID: 32076059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The COP9 signalosome mediates beta-catenin degradation by deneddylation and blocks adenomatous polyposis coli destruction via USP15.
    Huang X; Langelotz C; Hetfeld-Pechoc BK; Schwenk W; Dubiel W
    J Mol Biol; 2009 Aug; 391(4):691-702. PubMed ID: 19576224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Divergent Axin and GSK-3 paralogs in the beta-catenin destruction complexes of tapeworms.
    Montagne J; Preza M; Castillo E; Brehm K; Koziol U
    Dev Genes Evol; 2019 Jul; 229(4):89-102. PubMed ID: 31041506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversible modification of adenomatous polyposis coli (APC) with K63-linked polyubiquitin regulates the assembly and activity of the β-catenin destruction complex.
    Tran H; Polakis P
    J Biol Chem; 2012 Aug; 287(34):28552-63. PubMed ID: 22761442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysing the impact of nucleo-cytoplasmic shuttling of β-catenin and its antagonists APC, Axin and GSK3 on Wnt/β-catenin signalling.
    Schmitz Y; Rateitschak K; Wolkenhauer O
    Cell Signal; 2013 Nov; 25(11):2210-21. PubMed ID: 23872074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. different Roles for the axin interactions with the SAMP versus the second twenty amino acid repeat of adenomatous polyposis coli.
    PLoS One; ; . PubMed ID: 24722208
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.